Placebo ELLIPTA inhaler

DEVICE2 trials

Sponsors

GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 3

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

WithdrawnNCT02731846

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2016-06-30End: 2016-11-30Updated: 2016-07-22

Phase 4

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

CompletedNCT02586506

GlaxoSmithKlineAsthma

Start: 2015-10-01End: 2016-02-04Updated: 2017-10-11